GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AngioDynamics Inc (NAS:ANGO) » Definitions » Pretax Margin %

AngioDynamics (AngioDynamics) Pretax Margin % : -265.68% (As of Feb. 2024)


View and export this data going back to 2004. Start your Free Trial

What is AngioDynamics Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. AngioDynamics's Pre-Tax Income for the three months ended in Feb. 2024 was $-199.7 Mil. AngioDynamics's Revenue for the three months ended in Feb. 2024 was $75.2 Mil. Therefore, AngioDynamics's pretax margin for the quarter that ended in Feb. 2024 was -265.68%.

The historical rank and industry rank for AngioDynamics's Pretax Margin % or its related term are showing as below:

ANGO' s Pretax Margin % Range Over the Past 10 Years
Min: -63.65   Med: -6.02   Max: 1.46
Current: -61.53


ANGO's Pretax Margin % is ranked worse than
70.65% of 821 companies
in the Medical Devices & Instruments industry
Industry Median: -0.52 vs ANGO: -61.53

AngioDynamics Pretax Margin % Historical Data

The historical data trend for AngioDynamics's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioDynamics Pretax Margin % Chart

AngioDynamics Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.43 -63.65 -12.39 -9.47 -16.07

AngioDynamics Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.97 -24.01 44.31 -15.96 -265.68

Competitive Comparison of AngioDynamics's Pretax Margin %

For the Medical Instruments & Supplies subindustry, AngioDynamics's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AngioDynamics's Pretax Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AngioDynamics's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where AngioDynamics's Pretax Margin % falls into.



AngioDynamics Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

AngioDynamics's Pretax Margin for the fiscal year that ended in May. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: May. 2023 )/Revenue (A: May. 2023 )
=-54.437/338.752
=-16.07 %

AngioDynamics's Pretax Margin for the quarter that ended in Feb. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Feb. 2024 )/Revenue (Q: Feb. 2024 )
=-199.74/75.182
=-265.68 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AngioDynamics  (NAS:ANGO) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


AngioDynamics Pretax Margin % Related Terms

Thank you for viewing the detailed overview of AngioDynamics's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


AngioDynamics (AngioDynamics) Business Description

Traded in Other Exchanges
Address
14 Plaza Drive, Latham, NY, USA, 12110
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. It generates maximum revenue from Endovascular Therapies. Geographically, the company derives a majority of its revenue from the United States.
Executives
Lorinda Burgess director 22 WEST FRONTAG ROAD, NORTHBROOK IL 60093
Karen A Licitra director C/O SI-BONE, INC., 471 EL CAMINO REAL, SUITE 101, SANTA CLARA CA 95050
Michael E Tarnoff director C/O ANGIODYNAMICS, INC., 14 PLAZA DRIVE, LATHAM NY 12110
Scott Centea officer: SVP/GM, VIT C/O ANGIODYNAMICS, INC., 14 PLAZA DRIVE, LATHAM NY 12110
Dave Helsel officer: SVP Global Operations and R&D 400 WOOD ROAD, BRAINTREE MA 02184
Laura Piccinini officer: SVP International C/O ANGIODYNAMICS INC., 14 PLAZA DRIVE, LATHAM NY 12110
Stephen A Trowbridge officer: SVP and General Counsel 14 PLAZA DRIVE, LATHAM NY 120110
James C Clemmer director, officer: President and CEO COVIDIEN PLC, 15 HAMPSHIRE STREET, MANSFIELD MA 02048
Wesley Johnson director
Chad Thomas Campbell officer: SVP/GM, Vascular Access 140 POKANOKET PATH, WRENTHAM MA 02093
Warren Jr Nighan officer: SVP Quality and Regulatory ANGIODYNAMICS, INC., 14 PLAZA DRIVE, LATHAM NY 12110
Richard C Rosenzweig officer: SVP and General Counsel C/O DENTSPLY SIRONA INC., 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Kevin J Gould director 247 WASHINGTON STREET, DUXBURY MA 02332
Brent J. Boucher officer: SVP and GM of Oncology 14 PLAZA DRIVE, LATHAM NY 12110
Michael Greiner officer: EVP and CFO C/O VISTAPRINT, 95 HAYDEN AVENUE, LEXINGTON MA 02421